Applying Genomic and Bioinformatic Resources to Human Adenovirus Genomes for Use in Vaccine Development and for Applications in Vector Development for Gene Delivery

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2011 Oct 14

PMID 21994597

Citations 12

Authors

Jason Seto

Michael P Walsh

Padmanabhan Mahadevan

Qiwei Zhang

Donald Seto

Affiliations

Soon will be listed here.

Abstract

Technological advances and increasingly cost-effect methodologies in DNA sequencing and computational analysis are providing genome and proteome data for human adenovirus research. Applying these tools, data and derived knowledge to the development of vaccines against these pathogens will provide effective prophylactics. The same data and approaches can be applied to vector development for gene delivery in gene therapy and vaccine delivery protocols. Examination of several field strain genomes and their analyses provide examples of data that are available using these approaches. An example of the development of HAdV-B3 both as a vaccine and also as a vector is presented.

Citing Articles

The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus.

Garcia-Machorro J, Ramirez-Salinas G, Martinez-Archundia M, Correa-Basurto J Vaccines (Basel). 2022; 10(11).

PMID: 36366353 PMC: 9693616. DOI: 10.3390/vaccines10111844.

Human Adenovirus Subtype 21a Isolates From Children With Severe Lower Respiratory Illness in China.

Liu W, Zhang L, Cai Y, Zhang Q, Chen D, Qiu S Front Microbiol. 2022; 13:924172.

PMID: 35783397 PMC: 9244545. DOI: 10.3389/fmicb.2022.924172.

Molecular Typing and Rapid Identification of Human Adenoviruses Associated With Respiratory Diseases Using Universal PCR and Sequencing Primers for the Three Major Capsid Genes: Penton Base, Hexon, and Fiber.

Wu X, Zhang J, Lan W, Quan L, Ou J, Zhao W Front Microbiol. 2022; 13:911694.

PMID: 35633710 PMC: 9133664. DOI: 10.3389/fmicb.2022.911694.

Genomics-based re-examination of the taxonomy and phylogeny of human and simian Mastadenoviruses: an evolving whole genomes approach, revealing putative zoonosis, anthroponosis, and amphizoonosis.

Kang J, Ismail A, Dehghan S, Rajaiya J, Allard M, Lim H Cladistics. 2021; 36(4):358-373.

PMID: 34618969 PMC: 8964269. DOI: 10.1111/cla.12422.

Development and Application of a Fast Method to Acquire the Accurate Whole-Genome Sequences of Human Adenoviruses.

Zhao S, Guan W, Ma K, Yan Y, Ou J, Zhang J Front Microbiol. 2021; 12:661382.

PMID: 34054762 PMC: 8160523. DOI: 10.3389/fmicb.2021.661382.

References

Short J, Vasu C, Holterman M, Curiel D, Pereboev A . Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Res. 2006; 122(1-2):144-53. PMC: 2203219. DOI: 10.1016/j.virusres.2006.07.009. View

Purkayastha A, Ditty S, Su J, McGraw J, Hadfield T, Tibbetts C . Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development. J Virol. 2005; 79(4):2559-72. PMC: 546560. DOI: 10.1128/JVI.79.4.2559-2572.2005. View

Stone D, Furthmann A, Sandig V, Lieber A . The complete nucleotide sequence, genome organization, and origin of human adenovirus type 11. Virology. 2003; 309(1):152-65. DOI: 10.1016/s0042-6822(02)00085-5. View

Ling L, Manos M, Gluzman Y . Sequence of the junction in adenovirus 2-SV40 hybrids: examples of illegitimate recombination. Nucleic Acids Res. 1982; 10(24):8099-112. PMC: 327072. DOI: 10.1093/nar/10.24.8099. View

Williams J, Grodzicker T, Sharp P, Sambrook J . Adenovirus recombination: physical mapping of crossover events. Cell. 1975; 4(2):113-9. DOI: 10.1016/0092-8674(75)90117-8. View

Zhu Z, Zhang Y, Xu S, Yu P, Tian X, Wang L . Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11. J Clin Microbiol. 2008; 47(3):697-703. PMC: 2650960. DOI: 10.1128/JCM.01769-08. View

Gao W, Robbins P, Gambotto A . Human adenovirus type 35: nucleotide sequence and vector development. Gene Ther. 2003; 10(23):1941-9. DOI: 10.1038/sj.gt.3302097. View

Bernt K, Liang M, Ye X, Ni S, Li Z, Ye S . A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication. J Virol. 2002; 76(21):10994-1002. PMC: 136641. DOI: 10.1128/jvi.76.21.10994-11002.2002. View

Madisch I, Harste G, Pommer H, Heim A . Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy. J Virol. 2005; 79(24):15265-76. PMC: 1316018. DOI: 10.1128/JVI.79.24.15265-15276.2005. View

10.

Graham F, Prevec L . Adenovirus-based expression vectors and recombinant vaccines. Biotechnology. 1992; 20:363-90. DOI: 10.1016/b978-0-7506-9265-6.50022-1. View

11.

Thacker E, Timares L, Matthews Q . Strategies to overcome host immunity to adenovirus vectors in vaccine development. Expert Rev Vaccines. 2009; 8(6):761-77. PMC: 3700409. DOI: 10.1586/erv.09.29. View

12.

Vora G, Lin B, Gratwick K, Meador C, Hansen C, Tibbetts C . Co-infections of adenovirus species in previously vaccinated patients. Emerg Infect Dis. 2006; 12(6):921-30. PMC: 3373024. DOI: 10.3201/eid1206.050245. View

13.

Henquell C, Boeuf B, Mirand A, Bacher C, Traore O, Dechelotte P . Fatal adenovirus infection in a neonate and transmission to health-care workers. J Clin Virol. 2009; 45(4):345-8. DOI: 10.1016/j.jcv.2009.04.019. View

14.

Etherington G, Dicks J, Roberts I . Recombination Analysis Tool (RAT): a program for the high-throughput detection of recombination. Bioinformatics. 2004; 21(3):278-81. DOI: 10.1093/bioinformatics/bth500. View

15.

Bray N, Pachter L . MAVID: constrained ancestral alignment of multiple sequences. Genome Res. 2004; 14(4):693-9. PMC: 383315. DOI: 10.1101/gr.1960404. View

16.

Su X, Ma X, Hong Z, Wu H, Wang Y, Chen L . [Epidemiological study of human type 5 adenovirus in Guangzhou using chemiluminescence for neutralizing antibody assay]. Nan Fang Yi Ke Da Xue Xue Bao. 2007; 27(9):1323-6. View

17.

Blasiole D, Metzgar D, Daum L, Ryan M, Wu J, Wills C . Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults. J Clin Microbiol. 2004; 42(4):1686-93. PMC: 387592. DOI: 10.1128/JCM.42.4.1686-1693.2004. View

18.

Stone D, Di Paolo N, Lieber A . Development of group B adenoviruses as gene transfer vectors. Biotechnol Genet Eng Rev. 2008; 22:101-23. DOI: 10.1080/02648725.2006.10648067. View

19.

Mahadevan P, Seto J, Tibbetts C, Seto D . Natural variants of human adenovirus type 3 provide evidence for relative genome stability across time and geographic space. Virology. 2009; 397(1):113-8. DOI: 10.1016/j.virol.2009.10.052. View

20.

Vogels R, Zuijdgeest D, van Rijnsoever R, Hartkoorn E, Damen I, de Bethune M . Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol. 2003; 77(15):8263-71. PMC: 165227. DOI: 10.1128/jvi.77.15.8263-8271.2003. View